Cytokinetics, Incorporated Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cytokinetics, Incorporated (CYTK) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.090.110.070.110.080.230.20
Short-Term Investments0.980.500.720.360.380.000.00
Cash & Short-Term Investments1.080.610.780.470.460.230.20
Accounts Receivable0.020.000.000.050.010.010.01
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.020.010.010.010.000.010.01
Total Current Assets1.110.630.800.540.470.230.21
Non-Current Assets
Property, Plant & Equipment (Net)0.140.150.160.150.020.000.00
Long-Term Investments0.150.040.050.150.040.000.00
Other Non-Current Assets0.010.010.010.010.010.000.00
Total Non-Current Assets0.290.200.220.310.060.060.00
Total Assets1.400.821.010.840.530.290.21
Current Liabilities
Accounts Payable0.020.020.030.020.010.020.01
Short-Term Debt0.030.010.000.000.000.000.00
Current Portion of Long-Term Debt0.010.010.000.000.000.000.00
Accrued Liabilities0.020.010.020.020.020.000.00
Deferred Revenue0.050.000.000.000.000.000.00
Other Current Liabilities0.080.010.000.000.000.000.00
Total Current Liabilities0.180.100.080.070.030.030.02
Non-Current Liabilities
Long-Term Debt0.760.610.610.140.140.050.04
Other Non-Current Liabilities0.600.380.300.180.000.000.12
Total Non-Current Liabilities1.361.111.040.530.220.130.16
Total Liabilities1.541.211.120.600.420.300.19
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-2.70-2.11-1.59-1.21-0.99-0.87-0.74
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital2.561.731.481.451.110.850.77
Shares Outstanding0.120.100.090.080.000.000.00
Total Stockholders' Equity-0.14-0.39-0.110.240.11-0.010.03
Total Liabilities & Equity1.400.821.010.840.530.290.21